Labiotech.eu

Innate Pharma Cancer immunotherapy header

News and Trends 22 Oct 2018

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold

A combination cancer immunotherapy from French biotech Innate Pharma was twice as effective at treating recurrent squamous cell carcinoma as standard therapy in a Phase II trial. Squamous cell carcinoma is a head and neck cancer that forms lesions in the mucous membranes of body cavities such as the mouth, nose and throat. “Patients are […]

October 22, 2018 - 2 minutesmins - By Jonathan Smith

Aelix Therapeutics Gilead Functional HIV Cure

News and Trends 19 Oct 2018

Spanish Biotech Partners Gilead to Develop Functional HIV Cure

AELIX Therapeutics and Gilead will run a clinical trial testing a combination of treatments that has potential to let HIV-infected people ditch lifelong therapy. The trial, which will run in Spain, is planned to start in early 2019 and will recruit around 90 patients in the early stages of HIV infection. After receiving the […]

October 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

BOTW silk biomaterials nerve repair lomazzo

Startup Scout 19 Oct 2018

This Biotech Spins Silk That Can Repair Nerves

We fly to Lomazzo, Italy, this week to visit Silk Biomaterials. As the name implies, the company is testing different medical applications of silk, such as in nerve repair. Mission: Founded in 2014, Silk Biomaterials uses silk as a scaffold material for medical applications such as vascular grafts and peripheral nerve repair. In many tissue […]

October 19, 2018 - 4 minutesmins - By Jonathan Smith

More News! 18 Oct 2018

Phase III Triumph for Topical Hormonal Acne Treatment

The Italian biotech Cassiopea reports good news for acne sufferers. Its hormonal anti-acne treatment Winlevi significantly helped to reduce acne in two Phase III trials. Winlevi, when applied to the skin, cleared the acne in more than twice as many participants with moderate or severe acne as placebo. The treatment also showed good safety results […]

October 18, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Oct 2018

Belgian Firm Will Develop Antibiotic Alternatives for Industrial Biotech Using CRISPR

Syngulon will be developing antibacterial peptides using CRISPR/Cas9 gene editing technology thanks to an agreement with ERS Genomics, which licenses out CRISPR intellectual property in the EU. CRISPR technology is a hot topic in the biotech industry because it makes gene editing faster and easier than other techniques. This could make it very useful in […]

October 17, 2018 - 2 minutesmins - By Jonathan Smith

More News! 17 Oct 2018

The EU Patent of the Best Selling Drug Has Expired, What Does it Mean for Biotech?

AbbVie’s Humira, a treatment for inflammatory disease and the world’s best-selling drug, is no longer patent-protected in the EU. Competitors are already taking advantage of it. Humira is an antibody drug, called adalimumab, that has been topping the lists of best-selling drugs for years. Last year alone, it made over €15B in sales worldwide. The […]

October 17, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 16 Oct 2018

Drug Combination for Rare Genetic Nerve Disorder Nails Phase III

A treatment developed by French biotech Pharnext has become the first clinically proven therapy for a rare genetic disorder that affects the nervous system. In a Phase III trial, the treatment reduced the level of disability of patients with Charcot-Marie-Tooth disease, a condition that affects peripheral nerves. This disease causes problems with walking, running and […]

October 16, 2018 - 2 minutesmins - By Jonathan Smith

Immunicum cancer immunotherapy dendritic cell

News and Trends 16 Oct 2018

Cancer Immunotherapy Biotech Raises €34M on Nasdaq Stockholm

The Swedish biotech Immunicum has issued shares worth up to almost €34M on Nasdaq Stockholm, in an effort to accelerate the development of its cancer immunotherapy. Immunicum plans to use most of the funding to run a Phase Ib/II clinical trial that will test its lead cell therapy candidate in combination with checkpoint inhibitors to […]

October 16, 2018 - 2 minutesmins - By Jonathan Smith

Interview 16 Oct 2018

Using the Skin Microbiome to Treat Acne

The microbes living on our skin can play an important role in skin conditions such as acne. Philip talked to Veronika Oudova, CEO and co-founder of the Belgian company S-Biomedic, about how the company plans to fight acne with microbes, and the challenges of launching products in a field that is still unfamiliar to regulators. […]

October 16, 2018 - 4 minutesmins - By Jonathan Smith

News and Trends 15 Oct 2018

Microsoft Signs its First Microbiome Partnership

Microsoft Genomics will work with Cambridge-based Eagle Genomics to scale up its artificial intelligence platform for microbiome research. In recent years, it has become evident that the microbes that inhabit our body are key to our health. The microbiome has been linked to conditions such as diabetes, cancer, Alzheimer’s, multiple sclerosis and many more. However, large-scale studies […]

October 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 15 Oct 2018

The 7 Best Biotech Startup Competitions in Europe

If you are looking for an opportunity to pitch your startup, look no further. Here’s a guide to the key European events for biotech startup competitions. Taking part in a pitch competition can help a biotech company get a headstart and make its name known to investors and other important players in the biotech industry. […]

October 15, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

More News! 14 Oct 2018

Living Instruments: Making Music with Yeast, Moss and Paramecia

These instruments are alive. Yeast, moss and paramecia are behind the unique sounds of Living Instruments, which will be performing a concert in Zurich on October 21st. Instead of strings or windpipes, the sounds of these instruments are generated by living beings. The sound of the ‘yeast organ’ is triggered by the bubbles produced by […]

October 14, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold

Spanish Biotech Partners Gilead to Develop Functional HIV Cure

This Biotech Spins Silk That Can Repair Nerves

Phase III Triumph for Topical Hormonal Acne Treatment

Belgian Firm Will Develop Antibiotic Alternatives for Industrial Biotech Using CRISPR

The EU Patent of the Best Selling Drug Has Expired, What Does it Mean for Biotech?

Drug Combination for Rare Genetic Nerve Disorder Nails Phase III

Cancer Immunotherapy Biotech Raises €34M on Nasdaq Stockholm

Using the Skin Microbiome to Treat Acne

Microsoft Signs its First Microbiome Partnership

The 7 Best Biotech Startup Competitions in Europe

Living Instruments: Making Music with Yeast, Moss and Paramecia

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!